© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Jessica Skarzynski
Articles
Carfilzomib Triplet Fails to Induce Superior PFS in Newly Diagnosed Multiple Myeloma
May 29, 2020
Carfilzomib combined with lenalidomide and dexamethasone failed to improve progression-free survival, compared with the current standard of care triplet of bortezomib, lenalidomide, and dexamethasone, in patients with newly diagnosed multiple myeloma.
Study Finds Increased Risk for Death Following Chemo Use in Patients with Thoracic Cancer, COVID-19
May 28, 2020
Chemotherapy use in patients with lung and other thoracic cancers who are also diagnosed with COVID-19 was found to be associated with an increased risk of death compared to other treatment methods.